NCT05012397 2024-10-17Milademetan in Advanced/Metastatic Solid TumorsRain Oncology IncPhase 2 Terminated40 enrolled 13 charts
NCT02034110 2023-08-21Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare CancersNovartisPhase 2 Completed206 enrolled 40 charts 4 FDA